"Just Enough" Sample Preparation: A Proven Trend in Sample Analysis - - Chromatography Online
"Just Enough" Sample Preparation: A Proven Trend in Sample Analysis


LCGC Europe
Volume 25, Issue 12, pp. 670-674


Figure 6: LC–MS-MS postcolumn infusion studies: (a) protein precipitation (Captiva, Agilent), (b) solid-phase extraction using a neutral polymeric cartridge, (c) liquid–liquid extraction with methyl-tert-butyl-ether and (d) lipid-stripped protein precipitation (Captiva NDLipids, Agilent).
A second example is also a protein precipitation but considering an area where ion suppression comes into play. The presence of phospholipids in plasma can cause ion suppression if analytes of interest coelute in the portion of a chromatogram where these phospholipids appear. Phospholipid MS-MS selectivity can be achieved by considering the m/e 184 → m/e 184 transition indicative of phospholipid and lysophosphatidylcholine elution. Figure 6(a) shows a typical infusion experiment result that is obtained from protein-precipitated plasma, followed by Captiva filtration (Agilent Technologies, Delaware, USA). If the drug or its metabolites were to coelute with these compounds, ion suppression may occur and the analytical results would be jeopardized. Thus, in this case the simple protein precipitation sample preparation procedure may not be enough to provide reliable data. By performing the more complex SPE [Figure 6(b)] or liquidliquid extraction [Figure 6(c)], the extract is now cleaner and many of the phosphorus-containing lipids are greatly reduced. To get the best overall performance, an even more sophisticated phospholipid reduction may be achieved with a selective SPE phase that removes the last traces of phosphorylated compounds [Figure 6(d)]. Luckily, a product called Captiva NDLipids , which is a combined membrane filtration and phospholipid removal 96-well plate, performs both operations at once and thus is a simple just enough solution to this problem.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters
Global E-newsletters subscribe here:




 

LCGC COLUMNISTS 2014

Column Watch: Ron Majors, established authority on new column technologies, keeps readers up-to-date with new sample preparation trends in all branches of chromatography and reviews developments. LATEST: When Bad Things Happen to Good Food: Applications of HPLC to Detect Food Adulteration


Perspectives in Modern HPLC: Michael W. Dong is a senior scientist in Small Molecule Drug Discovery at Genentech in South San Francisco, California. He is responsible for new technologies, automation, and supporting late-stage research projects in small molecule analytical chemistry and QC of small molecule pharmaceutical sciences. LATEST: HPLC for Characterization and Quality Control of Therapeutic Monoclonal Antibodies


MS — The Practical Art: Kate Yu brings her expertise in the field of mass spectrometry and hyphenated techniques to the pages of LCGC. In this column she examines the mass spectrometric side of coupled liquid and gas-phase systems. Troubleshooting-style articles provide readers with invaluable advice for getting the most from their mass spectrometers. LATEST: Radical Mass Spectrometry as a New Frontier for Bioanalysis


LC Troubleshooting: LC Troubleshooting sets about making HPLC methods easier to master. By covering the basics of liquid chromatography separations and instrumentation, John Dolan is able to highlight common problems and provide remedies for them. LATEST: How Much Can I Inject? Part I: Injecting in Mobile Phase


More LCGC Columnists>>

LCGC North America Editorial Advisory Board>>

LCGC Europe Editorial Advisory Board>>

LCGC Editorial Team Contacts>>


Source: LCGC Europe,
Click here